Singular Genomics Systems, Inc.

Q: Sep 30 2024

Q: Jun 30 2024

Q: Mar 31 2024

FY: Dec 31 2023

Q: Sep 30 2023

Q: Jun 30 2023

Q: Mar 31 2023

FY: Dec 31 2022

Q: Sep 30 2022

Q: Jun 30 2022

Q: Mar 31 2022

FY: Dec 31 2021

Q: Sep 30 2021

Q: Jun 30 2021

Entry into a Material Definitive Agreement

Submission of Matters to a Vote of Security Holders

Other Events

Entry into a Material Definitive Agreement

2.02,9.01

Other Events

Other Events

8.01,9.01

2.02,9.01

1.01,9.01

8.01,9.01

5.03

5.07

2.02,9.01

2.02,9.01

3.01

2.02,9.01

2.02,9.01

1.01,1.02

2.02,9.01

Notification of removal from listing and/or registration on a national securities exchange

Post Effective Amendment to S-8

Post Effective Amendment to S-8

Notice of Effectiveness

Post-effective amendment to a registration statement

Post Effective Amendment to S-8

Post Effective Amendment to S-8

Post Effective Amendment to S-8

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Registration statement under Securities Act of 1933

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Prospectus Supplement with Pricing Information

Certification of approval for listing and registration on a national securities exchange

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Notice of Effectiveness

No description available

Additional Information for Proxy Statement/ Votes

No description available

No description available

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Preliminary Proxy Statement

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

ARCH Venture Fund IX, L.P.

TANG KEVIN; TANG CAPITAL PARTNERS LP; TANG CAPITAL MANAGEMENT LLC

Spaventa Andrew

BARKER DAVID L

Eisenberg Marcia

Kamdar Kim P.

Mardis Elaine R

Pellini Michael J

Ryan Jason

Ghai Jyotsna

Glezer Eli N.

Meeter Dalen

Flynn James E

Spaventa Andrew

Glezer Eli N.

Ghai Jyotsna

Meeter Dalen

Domain Partners IX, L.P.

Ghai Jyotsna

Flynn James E

Annual Report Scanned (Paper)

Annual Report Scanned (Paper)

Letter from the SEC

Correspondence with the SEC

No description available

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

No description available

Letter from the SEC

Draft registration statement (confidential submission) (amendment)

No description available

Letter from the SEC

Draft registration statement (confidential submission)